EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN
The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significa...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
S S Rodionova [verfasserIn] U R Khakimov [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch ; Russisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
In: Остеопороз и остеопатии - Endocrinology Research Centre, 2018, 19(2016), 1, Seite 22-27 |
|---|---|
| Übergeordnetes Werk: |
volume:19 ; year:2016 ; number:1 ; pages:22-27 |
| Links: |
Link aufrufen |
|---|
| DOI / URN: |
10.14341/osteo2016122-27 |
|---|
| Katalog-ID: |
DOAJ049544950 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ049544950 | ||
| 003 | DE-627 | ||
| 005 | 20230308143838.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.14341/osteo2016122-27 |2 doi | |
| 035 | |a (DE-627)DOAJ049544950 | ||
| 035 | |a (DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a rus | ||
| 050 | 0 | |a RZ301-397.5 | |
| 100 | 0 | |a S S Rodionova |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. | ||
| 650 | 4 | |a остеопороз у мужчин | |
| 650 | 4 | |a первичные формы остеопороза у мужчин | |
| 650 | 4 | |a альфакальцидол | |
| 650 | 4 | |a карбонат кальция | |
| 650 | 4 | |a МПК | |
| 653 | 0 | |a Osteopathy | |
| 700 | 0 | |a U R Khakimov |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Остеопороз и остеопатии |d Endocrinology Research Centre, 2018 |g 19(2016), 1, Seite 22-27 |w (DE-627)1760648779 |x 23110716 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2016 |g number:1 |g pages:22-27 |
| 856 | 4 | 0 | |u https://doi.org/10.14341/osteo2016122-27 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7 |z kostenfrei |
| 856 | 4 | 0 | |u https://endojournals.ru/index.php/osteo/article/view/8942 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2072-2680 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2311-0716 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2016 |e 1 |h 22-27 | ||
| author_variant |
s s r ssr u r k urk |
|---|---|
| matchkey_str |
article:23110716:2016----::fetf5erlaacdlramnicmiainihacucroaenoeieadniynhpia |
| hierarchy_sort_str |
2016 |
| callnumber-subject-code |
RZ |
| publishDate |
2016 |
| allfields |
10.14341/osteo2016122-27 doi (DE-627)DOAJ049544950 (DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. остеопороз у мужчин первичные формы остеопороза у мужчин альфакальцидол карбонат кальция МПК Osteopathy U R Khakimov verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 19(2016), 1, Seite 22-27 (DE-627)1760648779 23110716 nnns volume:19 year:2016 number:1 pages:22-27 https://doi.org/10.14341/osteo2016122-27 kostenfrei https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8942 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2016 1 22-27 |
| spelling |
10.14341/osteo2016122-27 doi (DE-627)DOAJ049544950 (DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. остеопороз у мужчин первичные формы остеопороза у мужчин альфакальцидол карбонат кальция МПК Osteopathy U R Khakimov verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 19(2016), 1, Seite 22-27 (DE-627)1760648779 23110716 nnns volume:19 year:2016 number:1 pages:22-27 https://doi.org/10.14341/osteo2016122-27 kostenfrei https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8942 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2016 1 22-27 |
| allfields_unstemmed |
10.14341/osteo2016122-27 doi (DE-627)DOAJ049544950 (DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. остеопороз у мужчин первичные формы остеопороза у мужчин альфакальцидол карбонат кальция МПК Osteopathy U R Khakimov verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 19(2016), 1, Seite 22-27 (DE-627)1760648779 23110716 nnns volume:19 year:2016 number:1 pages:22-27 https://doi.org/10.14341/osteo2016122-27 kostenfrei https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8942 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2016 1 22-27 |
| allfieldsGer |
10.14341/osteo2016122-27 doi (DE-627)DOAJ049544950 (DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. остеопороз у мужчин первичные формы остеопороза у мужчин альфакальцидол карбонат кальция МПК Osteopathy U R Khakimov verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 19(2016), 1, Seite 22-27 (DE-627)1760648779 23110716 nnns volume:19 year:2016 number:1 pages:22-27 https://doi.org/10.14341/osteo2016122-27 kostenfrei https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8942 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2016 1 22-27 |
| allfieldsSound |
10.14341/osteo2016122-27 doi (DE-627)DOAJ049544950 (DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7 DE-627 ger DE-627 rakwb eng rus RZ301-397.5 S S Rodionova verfasserin aut EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. остеопороз у мужчин первичные формы остеопороза у мужчин альфакальцидол карбонат кальция МПК Osteopathy U R Khakimov verfasserin aut In Остеопороз и остеопатии Endocrinology Research Centre, 2018 19(2016), 1, Seite 22-27 (DE-627)1760648779 23110716 nnns volume:19 year:2016 number:1 pages:22-27 https://doi.org/10.14341/osteo2016122-27 kostenfrei https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7 kostenfrei https://endojournals.ru/index.php/osteo/article/view/8942 kostenfrei https://doaj.org/toc/2072-2680 Journal toc kostenfrei https://doaj.org/toc/2311-0716 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 19 2016 1 22-27 |
| language |
English Russian |
| source |
In Остеопороз и остеопатии 19(2016), 1, Seite 22-27 volume:19 year:2016 number:1 pages:22-27 |
| sourceStr |
In Остеопороз и остеопатии 19(2016), 1, Seite 22-27 volume:19 year:2016 number:1 pages:22-27 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
остеопороз у мужчин первичные формы остеопороза у мужчин альфакальцидол карбонат кальция МПК Osteopathy |
| isfreeaccess_bool |
true |
| container_title |
Остеопороз и остеопатии |
| authorswithroles_txt_mv |
S S Rodionova @@aut@@ U R Khakimov @@aut@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
1760648779 |
| id |
DOAJ049544950 |
| language_de |
englisch russisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ049544950</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308143838.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14341/osteo2016122-27</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ049544950</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RZ301-397.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S S Rodionova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеопороз у мужчин</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">первичные формы остеопороза у мужчин</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">альфакальцидол</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">карбонат кальция</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">МПК</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Osteopathy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">U R Khakimov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Остеопороз и остеопатии</subfield><subfield code="d">Endocrinology Research Centre, 2018</subfield><subfield code="g">19(2016), 1, Seite 22-27</subfield><subfield code="w">(DE-627)1760648779</subfield><subfield code="x">23110716</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:22-27</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14341/osteo2016122-27</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://endojournals.ru/index.php/osteo/article/view/8942</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2072-2680</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2311-0716</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">22-27</subfield></datafield></record></collection>
|
| callnumber-first |
R - Medicine |
| author |
S S Rodionova |
| spellingShingle |
S S Rodionova misc RZ301-397.5 misc остеопороз у мужчин misc первичные формы остеопороза у мужчин misc альфакальцидол misc карбонат кальция misc МПК misc Osteopathy EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN |
| authorStr |
S S Rodionova |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)1760648779 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
DOAJ |
| remote_str |
true |
| callnumber-label |
RZ301-397 |
| illustrated |
Not Illustrated |
| issn |
23110716 |
| topic_title |
RZ301-397.5 EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN остеопороз у мужчин первичные формы остеопороза у мужчин альфакальцидол карбонат кальция МПК |
| topic |
misc RZ301-397.5 misc остеопороз у мужчин misc первичные формы остеопороза у мужчин misc альфакальцидол misc карбонат кальция misc МПК misc Osteopathy |
| topic_unstemmed |
misc RZ301-397.5 misc остеопороз у мужчин misc первичные формы остеопороза у мужчин misc альфакальцидол misc карбонат кальция misc МПК misc Osteopathy |
| topic_browse |
misc RZ301-397.5 misc остеопороз у мужчин misc первичные формы остеопороза у мужчин misc альфакальцидол misc карбонат кальция misc МПК misc Osteopathy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Остеопороз и остеопатии |
| hierarchy_parent_id |
1760648779 |
| hierarchy_top_title |
Остеопороз и остеопатии |
| isfreeaccess_txt |
true |
| familylinks_str_mv |
(DE-627)1760648779 |
| title |
EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN |
| ctrlnum |
(DE-627)DOAJ049544950 (DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7 |
| title_full |
EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN |
| author_sort |
S S Rodionova |
| journal |
Остеопороз и остеопатии |
| journalStr |
Остеопороз и остеопатии |
| callnumber-first-code |
R |
| lang_code |
eng rus |
| isOA_bool |
true |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
txt |
| container_start_page |
22 |
| author_browse |
S S Rodionova U R Khakimov |
| container_volume |
19 |
| class |
RZ301-397.5 |
| format_se |
Elektronische Aufsätze |
| author-letter |
S S Rodionova |
| doi_str_mv |
10.14341/osteo2016122-27 |
| author2-role |
verfasserin |
| title_sort |
effect of a 5-year alfacalcidol treatment in combination with calcium carbonate on bone mineral density in the primary forms of systemic osteoporosis in men |
| callnumber |
RZ301-397.5 |
| title_auth |
EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN |
| abstract |
The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. |
| abstractGer |
The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. |
| abstract_unstemmed |
The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
| container_issue |
1 |
| title_short |
EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN |
| url |
https://doi.org/10.14341/osteo2016122-27 https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7 https://endojournals.ru/index.php/osteo/article/view/8942 https://doaj.org/toc/2072-2680 https://doaj.org/toc/2311-0716 |
| remote_bool |
true |
| author2 |
U R Khakimov |
| author2Str |
U R Khakimov |
| ppnlink |
1760648779 |
| callnumber-subject |
RZ - Other Systems of Medicine |
| mediatype_str_mv |
c |
| isOA_txt |
true |
| hochschulschrift_bool |
false |
| doi_str |
10.14341/osteo2016122-27 |
| callnumber-a |
RZ301-397.5 |
| up_date |
2024-07-03T23:49:14.318Z |
| _version_ |
1803603730045599744 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ049544950</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308143838.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14341/osteo2016122-27</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ049544950</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJb644241a02ef479ab4c30c03b5fdffb7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RZ301-397.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">S S Rodionova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">EFFECT OF A 5-YEAR ALFACALCIDOL TREATMENT IN COMBINATION WITH CALCIUM CARBONATE ON BONE MINERAL DENSITY IN THE PRIMARY FORMS OF SYSTEMIC OSTEOPOROSIS IN MEN</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The article presents the results of 5-year treatment with a combination of alfacalcidol and calcium carbonate in 47 men with primary forms of systemic osteoporosis. The obtained results show the effectiveness of this treatment in patients with low and normal turnover forms of osteoporosis. Significant increase of BMD at L1-L4 was observed after the first year of treatment, at the Neck region - after 3-rd year of treatment. Comparison of the magnitude of the annual increase of BMD has shown that the effectiveness of the treatment increases with its duration. The possibility of hypercalcemia was excluded by monitoring of calcium levels in blood and urine at intervals of 3-6 months throughout the treatment period.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">остеопороз у мужчин</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">первичные формы остеопороза у мужчин</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">альфакальцидол</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">карбонат кальция</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">МПК</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Osteopathy</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">U R Khakimov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Остеопороз и остеопатии</subfield><subfield code="d">Endocrinology Research Centre, 2018</subfield><subfield code="g">19(2016), 1, Seite 22-27</subfield><subfield code="w">(DE-627)1760648779</subfield><subfield code="x">23110716</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:19</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:22-27</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.14341/osteo2016122-27</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/b644241a02ef479ab4c30c03b5fdffb7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://endojournals.ru/index.php/osteo/article/view/8942</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2072-2680</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2311-0716</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">19</subfield><subfield code="j">2016</subfield><subfield code="e">1</subfield><subfield code="h">22-27</subfield></datafield></record></collection>
|
| score |
7.3986406 |